259 related articles for article (PubMed ID: 36674874)
21. H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features.
Makise N; Sekimizu M; Konishi E; Motoi T; Kubo T; Ikoma H; Watanabe SI; Okuma T; Hiraoka N; Fukayama M; Kawai A; Ichikawa H; Yoshida A
Mod Pathol; 2019 Mar; 32(3):435-445. PubMed ID: 30291346
[TBL] [Abstract][Full Text] [Related]
22. Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone.
van Oosterwijk JG; de Jong D; van Ruler MA; Hogendoorn PC; Dijkstra PD; van Rijswijk CS; Machado I; Llombart-Bosch A; Szuhai K; Bovée JV
BMC Cancer; 2012 Aug; 12():375. PubMed ID: 22928481
[TBL] [Abstract][Full Text] [Related]
23. A genetic model for central chondrosarcoma evolution correlates with patient outcome.
Cross W; Lyskjær I; Lesluyes T; Hargreaves S; Strobl AC; Davies C; Waise S; Hames-Fathi S; Oukrif D; Ye H; Amary F; Tirabosco R; Gerrand C; Baker T; Barnes D; Steele C; Alexandrov L; Bond G; ; Cool P; Pillay N; Van Loo P; Flanagan AM
Genome Med; 2022 Aug; 14(1):99. PubMed ID: 36042521
[TBL] [Abstract][Full Text] [Related]
24. Chondrosarcoma: biology, genetics, and epigenetics.
Chow WA
F1000Res; 2018; 7():. PubMed ID: 30519452
[TBL] [Abstract][Full Text] [Related]
25. Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes.
Rozeman LB; de Bruijn IH; Bacchini P; Staals EL; Bertoni F; Bovée JV; Hogendoorn PC
Mod Pathol; 2009 Nov; 22(11):1489-98. PubMed ID: 19734846
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis and prognosis of chondrosarcoma of bone.
Rozeman LB; Hogendoorn PC; Bovée JV
Expert Rev Mol Diagn; 2002 Sep; 2(5):461-72. PubMed ID: 12271817
[TBL] [Abstract][Full Text] [Related]
27. Digital PCR analysis of circulating tumor DNA: a biomarker for chondrosarcoma diagnosis, prognostication, and residual disease detection.
Gutteridge A; Rathbone VM; Gibbons R; Bi M; Archard N; Davies KEJ; Brown J; Plagnol V; Pillay N; Amary F; O'Donnell P; Gupta M; Tirabosco R; Flanagan AM; Forshew T
Cancer Med; 2017 Oct; 6(10):2194-2202. PubMed ID: 28834325
[TBL] [Abstract][Full Text] [Related]
28. Dedifferentiated peripheral chondrosarcomas. A report of seven cases.
Bertoni F; Present D; Bacchini P; Picci P; Pignatti G; Gherlinzoni F; Campanacci M
Cancer; 1989 May; 63(10):2054-9. PubMed ID: 2702574
[TBL] [Abstract][Full Text] [Related]
29. Genomic Profiling of Low-grade Intramedullary Cartilage Tumors Can Distinguish Enchondroma From Chondrosarcoma.
Joseph NM; McGill KC; Horvai AE
Am J Surg Pathol; 2021 Jun; 45(6):812-819. PubMed ID: 33239505
[TBL] [Abstract][Full Text] [Related]
30. The clinical management of chondrosarcoma.
Riedel RF; Larrier N; Dodd L; Kirsch D; Martinez S; Brigman BE
Curr Treat Options Oncol; 2009 Apr; 10(1-2):94-106. PubMed ID: 19238552
[TBL] [Abstract][Full Text] [Related]
31. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
Machado I; Navarro S; Picci P; Llombart-Bosch A
Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
[TBL] [Abstract][Full Text] [Related]
32. Dedifferentiated chondrosarcoma: current standards of care.
Kattepur AK; Jones RL; Gulia A
Future Oncol; 2021 Dec; 17(35):4983-4991. PubMed ID: 34734747
[TBL] [Abstract][Full Text] [Related]
33. Conventional chondrosarcoma with focal clear cell change: a clinicopathological and molecular analysis.
Lam SW; van Langevelde K; Suurmeijer AJH; Cleven AHG; Bovée JVMG
Histopathology; 2019 Dec; 75(6):843-852. PubMed ID: 31297850
[TBL] [Abstract][Full Text] [Related]
34. Do Patient-derived Spheroid Culture Models Have Relevance in Chondrosarcoma Research?
Ma R; Mandell J; Lu F; Heim T; Schoedel K; Duensing A; Watters RJ; Weiss KR
Clin Orthop Relat Res; 2021 Mar; 479(3):477-490. PubMed ID: 32469486
[TBL] [Abstract][Full Text] [Related]
35. Is Needle Biopsy Clinically Useful in Preoperative Grading of Central Chondrosarcoma of the Pelvis and Long Bones?
Roitman PD; Farfalli GL; Ayerza MA; Múscolo DL; Milano FE; Aponte-Tinao LA
Clin Orthop Relat Res; 2017 Mar; 475(3):808-814. PubMed ID: 26883651
[TBL] [Abstract][Full Text] [Related]
36. Rb-loss is associated with high malignancy in chondrosarcoma.
Röpke M; Boltze C; Meyer B; Neumann HW; Roessner A; Schneider-Stock R
Oncol Rep; 2006 Jan; 15(1):89-95. PubMed ID: 16328039
[TBL] [Abstract][Full Text] [Related]
37. Integrating Morphology and Genetics in the Diagnosis of Cartilage Tumors.
de Andrea CE; San-Julian M; Bovée JVMG
Surg Pathol Clin; 2017 Sep; 10(3):537-552. PubMed ID: 28797501
[TBL] [Abstract][Full Text] [Related]
38. Multimodality Treatment of Skull Base Chondrosarcomas: The Role of Histology Specific Treatment Protocols.
Raza SM; Gidley PW; Meis JM; Grosshans DR; Bell D; DeMonte F
Neurosurgery; 2017 Sep; 81(3):520-530. PubMed ID: 28368506
[TBL] [Abstract][Full Text] [Related]
39. The imaging of cartilaginous bone tumours. II. Chondrosarcoma.
Douis H; Saifuddin A
Skeletal Radiol; 2013 May; 42(5):611-26. PubMed ID: 23053201
[TBL] [Abstract][Full Text] [Related]
40. Peripheral and periosteal chondrosarcoma: MRI-pathological correlation in 58 cases.
Tilden W; Andrei V; O'Donnell P; Saifuddin A
Skeletal Radiol; 2022 Jun; 51(6):1189-1199. PubMed ID: 34714386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
